Revelation Biosciences, Inc. (NASDAQ:REVBW) Short Interest Down 97.6% in May

Revelation Biosciences, Inc. (NASDAQ:REVBW) was the recipient of a significant drop in short interest in the month of May. As of May 15th, there was short interest totaling 1,162 shares, a drop of 97.6% from the April 30th total of 48,365 shares. Based on an average daily trading volume, of 202,279 shares, the short-interest ratio is presently 0.0 days.

Revelation Biosciences Trading Down 1.7%

REVBW stock traded down $0.00 during midday trading on Friday, reaching $0.01. 8,454 shares of the company’s stock traded hands, compared to its average volume of 89,065. Revelation Biosciences has a fifty-two week low of $0.01 and a fifty-two week high of $0.04. The business has a 50-day moving average price of $0.01 and a two-hundred day moving average price of $0.01.

Revelation Biosciences Company Profile

Revelation Biosciences, Inc (NASDAQ: REVBW) is a clinical-stage molecular diagnostics company focused on the rapid detection of life-threatening bacterial infections. The company leverages next-generation sequencing (NGS) to analyze cell-free microbial DNA in patient blood samples, with an emphasis on early identification of pathogens in bloodstream infections and hospital-acquired pneumonia. By targeting critically ill patients, Revelation Biosciences aims to shorten time to diagnosis and guide more effective antimicrobial therapy.

The company’s technology platform integrates high-throughput DNA sequencing with proprietary bioinformatics algorithms to differentiate pathogenic microbes from background microbial DNA.